- Report
- March 2022
- 324 Pages
Global
From €9107EUR$9,500USD£7,610GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1438EUR$1,500USD£1,202GBP
- Report
- February 2024
- 115 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- February 2024
- 100 Pages
Global
From €3500EUR$3,911USD£3,027GBP
- Report
- November 2021
- 600 Pages
Global
From €3835EUR$4,000USD£3,204GBP
Tramadol is an opioid analgesic used to treat moderate to severe pain. It is a centrally acting synthetic opioid analgesic, similar to codeine, and is available in both immediate-release and extended-release formulations. Tramadol is used to treat a variety of conditions, including chronic pain, post-operative pain, and pain associated with cancer. It is also used to treat neuropathic pain, fibromyalgia, and other conditions. Tramadol is generally well-tolerated, but can cause side effects such as nausea, dizziness, and constipation.
The analgesic market is highly competitive, with a variety of products available. Tramadol is one of the most commonly prescribed analgesics, and is available in both generic and branded formulations. It is available in both oral and injectable forms, and is often used in combination with other analgesics.
Some companies in the Tramadol market include Mylan, Teva Pharmaceuticals, and Actavis. Show Less Read more